BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

NeuroSigma, Inc. 

10960 Wilshire Boulevard
Suite 1230
Los Angeles  California  90024  U.S.A.
Phone: 310-479-3100 Fax: n/a


SEARCH JOBS




Industry
Medical Device






 Company News
NeuroSigma, Inc. And The U.S. Veterans Administration (VA) Enter Into Cooperative Research And Development Agreement (CRADA) 10/15/2014 8:28:43 AM
Epilepsy Device Maker NeuroSigma, Inc. Sets Terms For $50 Million IPO 9/29/2014 4:22:11 PM
NeuroSigma, Inc. Files Registration Statement for Proposed Initial Public Offering 8/27/2014 7:48:43 AM
U.S. Army Funds Phase 2 Clinical Trial At University of California, Los Angeles (UCLA) For The Treatment Of PTSD With The NeuroSigma, Inc. eTNS System 8/25/2014 8:10:31 AM
Enrollment Commences In NeuroSigma, Inc.-Sponsored Pediatric Clinical Trial For The Treatment Of Lennox-Gastaut Syndrome 7/22/2014 11:25:04 AM
National Institutes of Health (NIH) Funds Phase 2 Clinical Trial At University of California, Los Angeles (UCLA) For The Treatment Of ADHD With NeuroSigma, Inc.'s eTNS Systemnational 7/9/2014 9:28:00 AM
NeuroSigma, Inc. Release: Advances In Trigeminal Nerve Stimulation Featured At European Congress On Epileptology In Stockholm, Sweden 7/8/2014 9:32:56 AM
NeuroSigma, Inc. Receives Approval From Australian Therapeutic Goods Administration To Market Its Monarch ™ Etns ™ System For The Adjunctive Treatment Of Drug-Resistant Epilepsy 4/1/2014 7:18:13 AM
NeuroSigma, Inc. Signs On Two Former Amgen (AMGN) Finance Executives 3/28/2014 6:20:07 AM
David Hayes, Former Partner At O'Melveny & Myers LLP And Haynes And Boone LLP, Joins NeuroSigma, Inc. As Chief Administrative Officer, General Counsel And Sr. Vice President 2/25/2014 6:50:08 AM
1234